Medivation Rejects Sanofi’s $9 Billion Bid

02.05.2016 - The board of US biopharmaceuticals producer Medivation has unanimously rejected French drugmaker Sanofi’s $9.3 billion bid to acquire the company. David Hung, founder, president...